About Extend biosciences inc.
Extend Biosciences Inc. is a biotechnology company that specializes in developing innovative drug delivery platform technologies to improve the pharmacokinetic properties of peptides and proteins. The company's mission is to enable the efficient and sustained delivery of these molecules, which have been notoriously difficult to bring to market due to their rapid removal from circulation prior to administering therapeutic benefits.
The team at Extend Biosciences Inc. is comprised of experienced scientists, engineers, and business professionals who are dedicated to advancing the field of drug delivery through cutting-edge research and development. Their expertise spans a wide range of disciplines, including chemistry, biology, materials science, and engineering.
One of the key advantages of Extend Biosciences Inc.'s technology is its ability to enhance the stability and bioavailability of peptides and proteins in vivo. This means that these molecules can remain active in the body for longer periods of time, allowing for more effective treatment outcomes with lower dosages.
Extend Biosciences Inc.'s technology also offers several other benefits over traditional drug delivery methods. For example, it can be used with a wide range of peptide and protein therapeutics without requiring any modifications or conjugations. Additionally, it has been shown to be safe and well-tolerated in preclinical studies.
The company's flagship product is called XTEN® technology - an unstructured polypeptide chain that can be fused with therapeutic peptides or proteins without affecting their activity or specificity. XTEN®-based drugs have demonstrated improved pharmacokinetics compared with conventional formulations in preclinical studies across multiple therapeutic areas such as oncology (e.g., antibody-drug conjugates), metabolic disorders (e.g., GLP-1 agonists), inflammation (e.g., cytokine inhibitors), among others.
Extend Biosciences Inc.'s innovative approach has garnered significant attention from investors as well as industry leaders within the pharmaceutical space. The company has secured funding from top-tier venture capital firms such as 5AM Ventures, The Column Group, and Venrock. It has also established partnerships with several leading pharmaceutical companies to develop and commercialize XTEN®-based therapeutics.
In conclusion, Extend Biosciences Inc. is a biotechnology company that is revolutionizing the field of drug delivery through its innovative platform technology. Its team of experts is dedicated to advancing the science of peptide and protein therapeutics by improving their pharmacokinetic properties and enabling more effective treatments for patients in need. With its cutting-edge technology and strong industry partnerships, Extend Biosciences Inc. is poised to become a major player in the biotech space in the years ahead.